Characteristic | Subclinical hypothyroidism, n=18 | Overt hypothyroidism, n=18 | Healthy controls, n=18 | P |
Age, years, mean ± SD | 37 ± 12.9 | 33.9 ± 12.1 | 36.8 ± 12.7 | 0.72 |
Gender, female, n (%) | 14 (63.6%) | 14 (63.6%) | 15 (68.2%) | 0.89 |
TSH, µIU/ml, median (range)
|
6.15 (4.6-34)
|
96.4 (10-140)
|
2.6 (0.9-3.9)
|
<0.001* ** *** |
Free T4, ng/dl, median (range) | 1.01 (0.78-1.53) | 0.33 (0.09-0.5) | 1.15 (0.89-1.40) | <0.001* |
Anti-TPO IU/ml, mean ± SD | 284.27 ± 98.0 | 345.1 ± 45.3 | 135.5 ± 30.3 | 0.21 |
Fasting serum glucose, mg/dl, mean ± SD
|
94.0 ± 7.0
|
95.1 ± 6.1
|
87.2 ± 8.06
|
0.04** *** |
BUN, mg/dl, mean ± SD | 13.4 ± 3.2 | 12.0 ± 4.6 | 14.8 ± 8.4 | 0.38 |
Creatinine, mg/dl, mean ± SD | 0.5 ± 0.1 | 0.6 ± 0.2 | 0.6 ± 0.1 | 0.41 |
Total cholesterol, mg/dl, mean ± SD | 171 ± 31.2 | 204 ± 51.7 | 186.2 ± 24.3 | 0.04* |
LDL, mg/dl, mean ± SD | 96.7 ± 25.3 | 116.2 ± 40.3 | 107.8 ± 27.6 | 0.19 |
HDL, mg/dl, mean ± SD | 47.2 ± 11.6 | 42.5 ± 10.5 | 53.5 ± 16.4 | 0.29 |
Triglycerides, mg/dl, mean ± SD | 117.7 ± 42.7 | 140.4 ± 52.1 | 137.5 ± 52.2 | 0.34 |
BMI, kg/m2, mean ± SD | 26.8 ± 4.7 | 29.2 ± 3.8 | 29.6 ± 3.6 | 0.50 |
Waist, cm, mean ± SD | 83.1 ± 11.5 | 85.6 ± 10.1 | 88.1 ± 7.8 | 0.19 |
WHI, mean ± SD | 0.78 ± 0.03 | 0.80 ± 0.06 | 0.83 ± 0.01 | 0.14 |
Systolic BP, mmHg, mean ± SD | 120.7 ± 15.1 | 124.3 ± 13.3 | 115.2 ± 14.8 | 0.18 |
Diastolic BP, mmHg, mean ± SD | 71.1 ± 9.3 | 74.1 ± 9.6 | 71.4 ± 8.8 | 0.60 |
Weekly dose of levothyroxine, mcg, median (range) | 350.0 (250-700) | 825 (600-1400) | 0 | <0.001* |